Orchestra BioMed (OBIO) director David Hochman buys 10,000 shares
Rhea-AI Filing Summary
Orchestra BioMed Holdings director and officer David P. Hochman bought 10,000 shares of Common Stock in an open-market purchase at a weighted average price of $4.29 per share. After this transaction, he directly owns 1,086,467 shares, with additional indirect holdings reported through several family trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
6 txns
Insider
Hochman David P
Role
See Remarks
Bought
10,000 shs ($43K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.0001 per share ("Common Stock") | 10,000 | $4.29 | $43K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock, par value $0.0001 per share ("Common Stock") — 1,086,467 shares (Direct);
Common Stock — 439,482 shares (Indirect, By the DPH 2008 Trust);
Common Stock — 2,000 shares (Indirect, By the Solomon Ascher Hochman 2019 Trust);
Common Stock — 2,000 shares (Indirect, By the Hannah Hochman 2019 Trust);
Common Stock — 2,000 shares (Indirect, By the Judah Herman Hochman 2019 Trust);
Common Stock — 3,140 shares (Indirect, By the NSH 2008 Family Trust)
Footnotes (1)
- F1. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.28 to $4.30. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
FAQ
What insider transaction did OBIO director David Hochman report?
David P. Hochman reported buying 10,000 shares of Orchestra BioMed Common Stock in an open-market transaction. The weighted average purchase price was $4.29 per share, based on multiple trades between $4.28 and $4.30 on the transaction date.
What does transaction code P mean in this OBIO Form 4 filing?
Transaction code P indicates an open-market or private purchase of securities. In this case, it confirms that David P. Hochman bought Orchestra BioMed Common Stock rather than selling or transferring shares for tax, gifting, or restructuring purposes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
